Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.62
+4.76 (2.33%)
AAPL  263.62
+3.05 (1.17%)
AMD  199.82
-3.55 (-1.75%)
BAC  52.92
+0.15 (0.29%)
GOOG  315.24
+11.68 (3.85%)
META  655.16
+10.38 (1.61%)
MSFT  397.04
-1.42 (-0.36%)
NVDA  189.45
+1.55 (0.82%)
ORCL  147.84
-8.69 (-5.55%)
TSLA  409.95
-1.76 (-0.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.